205
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Synthesis and Biological Evaluation of 2-(4,5,6,7-Tetrahydrobenzo[c]Isoxazol-3-yl)-4H-Chromen-4-Ones

, ORCID Icon, , , , , , & show all
Pages 6337-6351 | Received 27 Feb 2021, Accepted 09 Sep 2021, Published online: 27 Sep 2021

References

  • J. Zhu, J. Mo, H. Z. Lin, Y. Chen, and H. P. Sun, “The Recent Progress of Isoxazole in Medicinal Chemistry,” Bioorganic & Medicinal Chemistry 26, no. 12 (2018): 3065–75.
  • A. Oubella, Y. A. Itto, A. Auhmani, A. Riahi, A. Robert, J. C. Dara, H. Morjani, C. A. Parish, and M. Esseffar, “Diastereoselective Synthesis and Cytotoxic Evaluation of New Isoxazoles and Pyrazoles with Monoterpenic Skeleton,” Journal of Molecular Structure 1198, (2019): 126924.
  • J. P. Nie, Z. Qu, Y. Chen, J. H. Chen, Y. Jiang, M. Jin, Y. Yu, W. Y. Niu, H. Duan, and N. Qin, “Discovery and anti-Diabetic Effects of Novel Isoxazole Based Flavonoid Derivatives,” Fitoterapia 142, (2020): 104499.
  • K. A. E. Abdelall, “Synthesis and Biological Evaluations of Novel Isoxazoles and Furoxan Derivative as anti-Inflammatory Agents,” Bioorganic Chemistry 94, (2020): 103441.
  • D. Zhang, J. Jia, L. Meng, W. Xu, L. Tang, and J. Wang, “Synthesis and Preliminary Antibacterial Evaluation of 2-Butyl Succinate-Based Hydroxamate Derivatives Containing Isoxazole Rings,” Archives of Pharmacal Research 33, no. 6 (2010): 831–42.
  • Maria M. M. Santos, Natália Faria, Jim Iley, Simon J. Coles, Michael B. Hursthouse, M. Luz Martins, and Rui Moreira, “Reaction of Naphthoquinones with Substituted Nitromethanes. Facile Synthesis and Antifungal Activity of naphtho[2,3-d]isoxazole-4,9-diones,” Bioorganic & Medicinal Chemistry Letters 20, no. 1 (2010): 193–5.
  • Ki Deok Shin, Mi-Young Lee, Dae-Seop Shin, Sangku Lee, Kwang-Hee Son, Sukhoon Koh, Young-Ki Paik, Byoung-Mog Kwon, and Dong Cho Han, “Blocking Tumor Cell Migration and Invasion with Biphenyl Isoxazole Derivative KRIBB3, a Synthetic Molecule That Inhibits Hsp27 Phosphorylation,” The Journal of Biological Chemistry 280, no. 50 (2005): 41439–48.
  • Z. Yang, P. Li, and X. Gan, “Novel Pyrazole-Hydrazone Derivatives Containing an Isoxazole Moiety: Design, Synthesis, and Antiviral Activity,” Molecules 23, (2018): 1798.
  • N. V. Balaji, B. HariBabu, V. U. Rao, G. V. Subbaraju, K. P. Nagasree, and M. M. K. Kumar, “Synthesis, Screening and Docking Analysis of Hispolon Pyrazoles and Isoxazoles as Potential Antitubercular Agents,” Current Topics in Medicinal Chemistry 19, no. 9 (2019): 662–82.
  • W. Li, J. Li, H. Shen, J. Cheng, Z. Li, and X. Xu, “Synthesis, Nematicidal Activity and Docking Study of Novel Chromone Derivatives Containing Substituted Pyrazole,” Chinese Chemical Letters 29, no. 6 (2018): 911–4.
  • Y. Duan, Y. Jiang, F. Guo, L. Chen, L. Xu, W. Zhang, and B. Liu, “The Antitumor Activity of Naturally Occurring Chromones: A Review,” Fitoterapia 135, (2019): 114–29.
  • C. Demetgul, and N. Beyazit, “Synthesis, Characterization and Antioxidant Activity of Chitosan-Chromone Derivatives,” Carbohydrate Polymers 181, (2018): 812–7.
  • J. N. Modranka, E. Nawrot, and J. Graczyk, “In Vivo Antitumor, in Vitro Antibacterial Activity and Alkylating Properties of Phosphorohydrazine Derivatives of Coumarin and Chromone,” European Journal of Medicinal Chemistry 41, no. 11 (2006): 1301–9.
  • C. Sun, C. Chen, S. Xu, J. Wang, Y. Zhu, D. Kong, H. Tao, M. Jin, P. Zheng, and W. Zhu, “Synthesis and Anticancer Activity of Novel 4-Morpholino-7,8-Dihydro-5H-Thiopyrano[4,3-d]Pyrimidine Derivatives Bearing Chromone Moiety,” Bioorganic & Medicinal Chemistry 24, no. 16 (2016): 3862–9.
  • P. Baruah, M. A. Rohman, S. O. Yesylevskyy, and S. Mitra, “Therapeutic Potency of Substituted Chromones as Alzheimer's Drug: Elucidation of Acetylcholinesterase Inhibitory Activity through Spectroscopic and Molecular Modelling Investigation,” BioImpacts: BI 9, no. 2 (2019): 79–88. BI,
  • H. Liu, R. Xu, L. Feng, W. Guo, N. Cao, C. Qian, P. Teng, L. Wang, X. Wu, Y. Sun, et al. “A Novel Chromone Derivative with anti-Inflammatory Property via Inhibition of ROS-Dependent Activation of TRAF6-ASK1-p38 Pathway,” PLoS One 7, no. 8 (2012): e37168.
  • N. C. Netzer, T. Kupper, H. W. Voss, and A. H. Eliasson, “The Actual Role of Sodium Cromoglycate in the Treatment of Asthma-a Critical Review,” Sleep & Breathing = Schlaf & Atmung 16, no. 4 (2012): 1027–32.
  • J. Sheikh, H. Juneja, V. Ingle, P. Ali, and T. B. Hadda, “Synthesis and in Vitro Biology of Co(II), Ni(II), Cu(II) and Zinc(II) Complexes of Functionalized Beta-Diketone Bearing Energy Buried Potential Antibacterial and Antiviral O,O Pharmacophore Sites,” Journal of Saudi Chemical Society 17, no. 3 (2013): 269–76.
  • T. V. Deepthi, and P. Venugopalan, “Synthesis, Characterization and Biological Studies on NiII and CuII Complexes of Two Novel α,β-Unsaturated 1,3-Diketones Related to Curcuminoids,” Inorganica Chimica Acta 450, (2016): 243–50.
  • V. Porchezhiyan, D. Kalaivani, J. Shobana, and S. E. Noorjahan, “Synthesis, Docking and in Vitro Evaluation of l-Proline Derived 1,3-Diketones Possessing anti-Cancer and anti-Inflammatory Activities,” Journal of Molecular Structure 1206, (2020): 127754.
  • T. Nishiyama, S. Shiotsu, and H. Tsujita, “Antioxidative Activity and Active Site of 1,3-Indandiones with the β-Diketone Moiety,” Polymer Degradation and Stability 76, no. 3 (2002): 435–9.
  • P. V. Badadhe, L. R. Patil, S. S. Bhagat, A. V. Chate, D. W. Shinde, M. D. Nikam, and C. H. Gill, “Synthesis and Antimicrobial Screening of Some Novel Chromones and Pyrazoles with Incorporated Isoxazole Moieties,” Journal of Heterocyclic Chemistry 50, (2013): n/a–1004.
  • W. Wang, L. Deng, C. Hu, Y. Zhang, Y. Li, and S. Zuo, “Synthesis of Isoxazole‐Linked Norcantharidin Analogues of Substituted Chromones,” Journal of Heterocyclic Chemistry 54, no. 3 (2017): 1806–11.
  • (a) S. G. Dengale, H. N. Akolkar, B. K. Karale, N. R. Darekar, S. D. Mhaske, M. H. Shaikh, D. N Raut and K. K. Deshmukh, “Synthesis of 3‐(trifluoromethyl)‐1‐ (perfluorophenyl)‐1H‐pyrazol‐5(4H)‐one derivatives via Knoevenagel condensation and their biological evaluation,” Journal of the Chinese Chemical Society, 68 (2021): 657-668; (b) S. P. Kunde, K. G. Kanade, B. K. Karale, H. N. Akolkar, S. S. Arbuj, P. V. Randhavane, S. T. Shinde, M. H. Shaikh and A. K. Kulkarni, “Nanostructured N doped TiO2 efficient stable catalyst for Kabachnik-Fields reaction under microwave irradiation,” RSC Advances, 10 (2020): 26997–27005; (c) H. N. Akolkar, S. J Takate, K. K. Deshmukh, B. K. Karale, N. R. Darekar, V. M. Khedkar and M. H. Shaikh “Design, Synthesis and Biological Evaluation of Novel Furan & Thiophene Containing Pyrazolyl Pyrazolines as Antimalarial Agents,” Polycyclic Aromatic Compounds, https://doi.org/10.1080/10406638.2020.1821231; (d) M. H. Shaikh, D. D. Subhedar, S. V. Akolkar, A. A, Nagargoje, V. M. Khedkar, D. Sarkar and B. B. Shingate, “Tetrazoloquinoline-1, 2, 3-Triazole Derivatives as Antimicrobial Agents: Synthesis, Biological Evaluation and Molecular Docking Study,” Polycyclic Aromatic Compounds, https://doi.org/10.1080/10406638.2020.1821229.
  • (a) Schrodinger Suite 2015-4 QM-Polarized Ligand Docking protocol; Glide version 6.9, Schrodinger, LLC, New York, NY,2006; Jaguar version 9.0, Schrodinger, LLC, New York, NY, 2015; QSite version 6.9, Schrodinger, LLC, New York, NY, 2015; (b) R. A. Friesner, R. B. Murphy, M. P. Repasky, L. L. Frye, J. R. Greenwood, T. A. Halgren, P. C. Sanschagrin and D. T. Mainz, “Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes,” Journal of Medicinal Chemistry, 2149 (2006): 6177–6196 and related references cited theirin.
  • S. Zhang, Y. Luo, L. Q. He, Z. J. Liu, A. Q. Jiang, Y. H. Yang, and H. L. Zhu, “Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 1,3,4-Oxadiazole Derivatives Possessing Benzotriazole Moiety as FAK Inhibitors with Anticancer Activity,” Bioorganic & Medicinal Chemistry 21, no. 13 (2013): 3723–9.
  • Molinspiration Chemoinformatics Brastislava, Slovak Republic, Available from: http://www.molinspiration.com/cgi-bin/properties 2014.
  • (a) P. Padmanabhan and S. N. Jangle, “Evaluation of in-vitro anti-inflammatory activity of herbal preparation, a combination of four medicinal plants,” International Journal of Basic and Applied Medical Sciences, 2 (2012): 109–116; (b) Y. Mizushima and M. Kobayashi, “Interaction of anti‐inflammatory drugs with serum proteins, especially with some biologically active proteins,” Journal of Pharmacy and Pharmacology, 20 (1968): 169–73; (c) G. Elias and M. N. Rao, “Inhibition of albumin denaturation and anti-inflammatory activity of dehydrozingerone and its analogs,” Indian Journal of Experimental Biology, 26 (1988): 540–542; (d) S. F. D. Nguemnang, E. G. Tsafack, M. Mbiantcha, A. Gilbert, A. D. Atsamo, N. W. Yousseu, M. M. V. Matah, C. F. Adjouzem, “In vitro anti-inflammatory and in vivo antiarthritic activities of aqueous and ethanolic extracts of Dissotis thollonii Cogn. (Melastomataceae) in rats,” Evidence-Based Complementary and Alternative Medicine 15(2019); (e) K. D. P. P. Gunathilake, K. K. D. S. Ranaweera and H. P. Vasantha Rupasinghe, “In vitro anti-inflammatory properties of selected green leafy vegetables”, Biomedicines 6 (2018): 107–116; (f) N. H. Grant, H. E. Alburn and C. Kryzanauskas, “Stabilization of serum albumin by anti-inflammatory drugs,” Biochemical Pharmacology 19 (1970): 715–722.
  • C. A. Lipinski, L. Lombardo, B. W. Dominy, and P. J. Feeney, “Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings,” Advanced Drug Delivery Reviews 46, no. 1-3 (2001): 3–26.
  • Yuan H. Zhao, Michael H. Abraham, Joelle Le, Anne Hersey, Chris N. Luscombe, Gordon Beck, Brad Sherborne, and Ian Cooper, “Rate Limited Steps of Human Oral Absorption and QSAR Studies,” Pharmaceutical Research 19, no. 10 (2002): 1446–57.
  • Drug-likeness and molecular property prediction, available from: http://www.molsoft.com/mprop/

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.